---
title: 'Director, National Payer Accounts at Cogent Biosciences'
canonical: 'https://feeny.ai/job/director-national-payer-accounts-cogent-biosciences-waltham-massachusetts-5jkvd1gj4bg7'
type: 'job'
last_seen: '2026-09-23'
---

# Director, National Payer Accounts at Cogent Biosciences

- **Company:** Cogent Biosciences
- **Location:** Waltham Massachusetts, United States
- **Posted:** 2026-09-22
- **Last confirmed live:** 2026-09-23
- **Apply:** https://job-boards.greenhouse.io/cogentbiosciences/jobs/4411472009

## Job description

Who We Are:

Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing.

The Role:

Position Overview:

- The Director, National Payer Accounts, is responsible for ensuring profitable coverage access with government accounts and key regional plans.
- Supporting execution of the Market Access objectives and strategy for the payer audience.
- Collaborating with internal partners but not limited to Market Access, Marketing, Commercial Operations, Sales and Medical to align approaches with our largest customers to ensure the best patient and provider experience.

Responsibilities:

- Execute specific customer strategy as it aligns with the overall product and organizational goals.
- Deliver the value of our products, services and the Cogent organization by managing interactions with all customer stakeholders.
- Develop and execute corporate strategies customized to the market access payer environment to help Cogent maximize its access and profitability.
- Lead all interactions with key strategic accounts.
- Monitor developments among government and private insurers/entities to support the Market Access strategies that will enable Cogent to anticipate and respond to market events.
- Develop, maintain, and build relationships with account senior management and decision makers.
- Monitor formulary and product access if applicable.
- Responsible for the development of the account plan and participate in business reviews.
- Provides subject matter expertise of the payer accounts to support and influence the development of the broader sales and marketing strategy.
- Execute brand strategy customized to the market access business environment to help Cogent maximize its access and profitability.
- Provide education and coaching to field colleagues on opportunities and/or overcome access challenges.
- Represent Cogent at key national and regional conferences
- Demonstrates a hands-on, result-oriented mindset, with flexibility and willingness to support others as needed.

Qualifications:

- Bachelor's degree required
- Minimum of 10 years in pharmaceutical industry with documented track record of success and first line sales management experience preferred.
- 5+ years’ experience with government accounts and key regional payer accounts with rare disease, hematology, and oncology experience preferred.
- Demonstrated ability to deliver on “clinical value first” and/or scientific product-related information to key stakeholders within key national accounts.
- Consistent track record of ensuring payer coverage and where needed, deliver on successful contract negotiation.
- Demonstrated ability to plan, analyze sales and payer data, demonstrated proficiency in contracting or negotiations across all key government payer customers and business segments (i.e. Commercial and Medicare).
- Strong business acumen includes persuasive business communication and presentation skills to both the external and internal stakeholders.
- Strong organizational skills, attention to detail, ability to prioritize, exhibit business judgment and identify opportunities.
- Proficiency in Microsoft Word, PowerPoint, and Excel, with the ability to create professional documents, presentations, and spreadsheets.
- Excellent collaboration and ability to work cross functionally.

Salary Range:

$240,000 to $275,000 USD

Target Bonus: 20%

Exact compensation will vary based on skills, experience, and location.

Our Locations

Waltham, MA: Our headquarters is located in the Greater Boston life sciences community, with an open, collaborative office environment designed to support teamwork and connection. Employees benefit from convenient on-site amenities, including free on-site parking and gym facilities in the building.

Boulder, CO: Our Boulder location is home to Cogent’s discovery research organization and a key scientific hub with strong leadership based on site. Situated in the greater Denver-Boulder biopharmaceutical corridor, this office plays a central role in advancing our discovery efforts and pipeline.

Our Offer To You

At Cogent Biosciences, we offer a competitive salary, bonus, and ongoing stock awards, alongside a benefits package that sets us apart. We cover 100% of medical, dental, and vision premiums for you and your family, and help reduce out-of-pocket costs by funding up to 75% of in-network deductibles. Our benefits also include a 401(k) match with immediate vesting, generous paid time off, 12 weeks of fully paid parental leave, paid family and medical leave for all employees regardless of location, and company-paid short-term disability coverage for up to 20 weeks. Additional perks like wellness programs, tuition reimbursement, and inclusive family-forming support help you thrive at work and beyond.

We are proud to be an Equal Opportunity Employer. Our goal is to have a diverse workforce. We do not discriminate on the basis of race, age, color, religion, national origin, gender, sexual orientation, gender identity or expression, veteran status or disability, or any other status protected under federal, state, or local law. All employment is decided on the basis of qualifications, merit, and business need.

## About Cogent Biosciences

## Company Overview
- **One-liner**: Cogent Biosciences is a publicly traded biotechnology company developing precision therapies for genetically defined diseases, with its lead program bezuclastinib targeting KIT D816V mutations in systemic mastocytosis and gastrointestinal stromal tumors.
- **Entity Type**: Public (NASDAQ: COGT)
- **Headquarters**: Waltham, Massachusetts, United States (with additional office in Boulder, Colorado)
- **Founded**: 2014
- **Founders**: Not publicly available

## Core Business
- **Primary industry**: Biotechnology research and therapeutics development
- **Target customers**: Patients with genetically defined diseases, healthcare providers, and pharmaceutical partners (B2B/B2C hybrid)
- **Mission**: “To discover, develop, and commercialize best-in-class therapies that have a dramatic impact for patients with genetically defined diseases” [cogentbio.com](https://www.cogentbio.com/)

## Products & Services
- **Bezuclastinib**: A selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation and other KIT exon 17 mutations. In late-stage clinical development for advanced systemic mastocytosis (AdvSM), non‑advanced SM, and advanced gastrointestinal stromal tumors (GIST). Positive registration‑directed trial results reported in 2025. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)
- **Novel JAK2 V617F inhibitor**: A potential best‑in‑class mutant‑selective JAK2 inhibitor currently in preclinical development, with data presented at the 2026 EHA Congress. [cogentbio.com](https://www.cogentbio.com/)
- **Additional pipeline programs**: Research‑stage targeted therapies addressing mutations in ErbB2, PI3Kα, KRAS, and JAK2. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)

## Market Standing
- **Valuation/Market Cap**: USD $762.7 million (as of mid‑2026, based on LinkedIn data) [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)
- **Key Metric**: Annual revenue of USD $7.9 million (likely from partnerships or grants); total funding to date ~USD $1.82 billion (including post‑IPO equity, debt, and Series A). [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)
- **Notable Investors/Partners**: Series A led by Atlas Venture and F‑Prime; post‑IPO equity rounds led by Commodore Capital (2024, $225M), Fairmount Funds Management (2020, $104.4M) [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)
- **Growth Signals**: Headcount grew 27.6% year‑over‑year to 223 employees; monthly LinkedIn follower growth of 3.0% (+61.7% annually); positive late‑stage trial results in 2025; expanded pipeline with new preclinical assets. [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)

## Competitive Advantages
- **Selective targeting of KIT D816V**: Bezuclastinib is designed to selectively and potently inhibit the key driver mutation in systemic mastocytosis, potentially offering a better safety/tolerability profile than earlier multi‑kinase inhibitors.
- **Late‑stage momentum**: Registration‑directed trials (APEX pivotal trial) have reported clinically meaningful results, positioning the company for potential regulatory submissions and commercialization.
- **Broad pipeline beyond KIT**: Research into JAK2, KRAS, PI3Kα, and ErbB2 mutations diversifies the platform and reduces single‑asset risk.
- **Strong capital position**: Over $760M market cap and access to public equity markets provide financial runway for multiple programs.

## Strategic Focus
- **Advance bezuclastinib to market**: Continue regulatory interactions and preparation for potential FDA approval in AdvSM and GIST, while expanding into non‑advanced SM.
- **Build a portfolio of precision therapies**: Invest in early‑stage discovery (Boulder, CO) to generate novel molecules targeting validated oncogenic drivers.
- **Commercial readiness**: Hiring commercial leadership (Chief Commercial Officer, Market Access, Field Medical Affairs) indicates preparation for a future product launch. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)

## Why Work Here
- **Culture**: Emphasizes collaboration, urgency, inquisitiveness, and ingenuity. Corporate values include “Patients are waiting” (urgency), “Learning excites us” (inquisitiveness), “Succeed Together” (trust), and “Navigate uncertainty” (ingenuity). [cogentbio.com](https://www.cogentbio.com/careers/)
- **Work model**: Hybrid/remote flexibility – many roles are listed as remote (e.g., Area Directors for Field Medical Affairs, Patient Educators), while research roles are onsite in Boulder, CO. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)
- **Growth and impact**: As a late‑stage clinical company with an expanding pipeline, employees have direct influence on programs that could change patient lives. Fast‑paced environment with high autonomy.

## Sources
1. [Cogent Biosciences Corporate Website](https://www.cogentbio.com/)
2. [Cogent Biosciences About Page](https://www.cogentbio.com/about/)
3. [Cogent Biosciences Careers Page](https://www.cogentbio.com/careers/)
4. [Cogent Biosciences Job Board (Greenhouse)](https://job-boards.greenhouse.io/cogentbiosciences)
5. [Cogent Biosciences LinkedIn Profile](https://www.linkedin.com/company/cogentbiosciences)

## Other roles at Cogent Biosciences

- [Director, Patient Advocacy & Engagement](https://feeny.ai/job/director-patient-advocacy-engagement-cogent-biosciences-waltham-massachusetts-mdfqz22t61ny) — Waltham Massachusetts, United States
- [Precision Medicine Executive - West](https://feeny.ai/job/precision-medicine-executive-west-cogent-biosciences-waltham-massachusetts-cpfmj6tnqafj) — Waltham Massachusetts, United States
- [Precision Medicine Executive - Southcentral](https://feeny.ai/job/precision-medicine-executive-southcentral-cogent-biosciences-waltham-s5r3r46sr7mx) — Waltham Massachusetts, United States
- [Precision Medicine Executive - Midwest](https://feeny.ai/job/precision-medicine-executive-midwest-cogent-biosciences-waltham-massachusetts-ver5wp31wzpx) — Waltham Massachusetts, United States
- [Precision Medicine Executive - Southeast](https://feeny.ai/job/precision-medicine-executive-southeast-cogent-biosciences-waltham-massachusetts-b4yx0ndnttra) — Waltham Massachusetts, United States
- [Precision Medicine Executive - Mid Atlantic](https://feeny.ai/job/precision-medicine-executive-mid-atlantic-cogent-biosciences-waltham-hkkacka3j7rv) — Waltham Massachusetts, United States
- [Precision Medicine Executive - Northeast](https://feeny.ai/job/precision-medicine-executive-northeast-cogent-biosciences-waltham-massachusetts-bw3ja7hsntc5) — Waltham Massachusetts, United States
- [Executive Director, Precision Medicine Executives](https://feeny.ai/job/executive-director-precision-medicine-executives-cogent-biosciences-waltham-21ccj080xhhc) — Waltham Massachusetts, United States
- [Manager, Communications and Investor Relations](https://feeny.ai/job/manager-communications-and-investor-relations-cogent-biosciences-waltham-am68edvhn0v0) — Waltham Massachusetts, United States
- [Research Associate, Pharmacology & Cell Biology](https://feeny.ai/job/research-associate-pharmacology-cell-biology-cogent-biosciences-boulder-colorado-6t4r2c47nb6t) — Boulder Colorado, United States